Samplix ApS supports the life sciences and medical research communities with proprietary microfluidics-based solutions and services designed to deliver the highest-resolution insights into cells and genomes. Samplix technology is designed for encapsulating biological material, including single cells, organelles and molecules, for a range of downstream analyses, such as assessments of single-cell enzyme activity, characterisation of edits in engineered genes, long- and short-read sequencing, and low-bias whole genome amplification.
As a leading developer of microfluidics solutions and services, Samplix stands ready to help academic, corporate and government researchers reach their goals in areas as diverse as human genomics, gene and cell therapy, plant genomics, and synthetic biology.
Location: Denmark, Capital Region of Denmark, Birkerød
Employees: 11-50
Phone: +45 82 30 45 00
Founded date: 2013
Investors 1
| Date | Name | Website |
| - | Fjord Capi... | fjordcap.c... |
Mentions in press and media 2
| Date | Title | Description | Source |
| 16.04.2024 | Adoptive Cell Therapy: Exploring and Influencing Heterogenei... | www.samplix.com In this free webinar, learn how to navigate the heterogeneity within bulk population... | prweb.com/... |
| - | Samplix | “Samplix has developed a unique microfluidics instrument called Xdrop, which enables rapid and accur... | fastfounde... |